According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings are HK$17.17 Million. In 2024 the company made an earning of -HK$0.29 Billion a decrease over its 2023 earnings that were of -HK$89.88 Million. The earnings displayed on this page is the company's Pretax Income.